Aster Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Aster Capital Management's REGN Position: Q2 2026 in Review
Aster Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 29,575% in Q2 2026, buying an estimated $1.61M and bringing the position to 2,374 shares worth $1.48M. The position accounts for 0.31% of the portfolio, ranked #93.
Aster Capital Management first reported a position in REGN in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.85M in Q1 2025. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Aster Capital Management held 2,374 shares of Regeneron Pharmaceuticals worth $1.48M as of Q2 2026.
- Aster Capital Management bought 2,366 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.61M.
- Regeneron Pharmaceuticals made up 0.31% of Aster Capital Management's portfolio in Q2 2026, its #93 holding.
- Aster Capital Management first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
- Aster Capital Management's Regeneron Pharmaceuticals position peaked at $1.85M in Q1 2025.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.